Details for Patent: 7,741,373
Which drugs does patent 7,741,373 protect, and when does it expire?
Patent 7,741,373 protects FIBRICOR and is included in one NDA.
Summary for Patent: 7,741,373
| Title: | Methods of use of fenofibric acid |
| Abstract: | Fenofibric acid formulations comprising 105 mg of fenofibric acid are described as well as methods of use thereof. Dosage forms include, for example, immediate-release dosage forms. |
| Inventor(s): | Kristin Anne Arnold, Hengsheng Feng |
| Assignee: | Deerfield Management Company Lp As Administrative Agent , Rosemont Pharmaceuticals LLC |
| Application Number: | US12/501,678 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 7,741,373
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosemount | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-001 | Aug 14, 2009 | DISCN | Yes | No | 7,741,373 | ⤷ Start Trial | ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA | ⤷ Start Trial | ||||
| Rosemount | FIBRICOR | fenofibric acid | TABLET;ORAL | 022418-002 | Aug 14, 2009 | DISCN | Yes | No | 7,741,373 | ⤷ Start Trial | ADJUNCTIVE THERAPY TO DIET TO PATIENTS WITH HYPERTRIGLYCERIDEMIA | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
